Tag: mifepristone

FDA Lifts Restriction on Remote Prescriptions of Abortion Drugs

– April 13, 2021

The Biden administration cited the coronavirus pandemic to give the green light to at-home, self-administered abortions on Monday.

The FDA said it will allow the prescription of an abortion pill, mifepristone, through the mail, reversing Trump administration restrictions on remote prescription of abortion drugs. The agency wrote that because “the in-person dispensing of mifepristone for medical termination of early pregnancy may present additional COVID-related risks to patients and healthcare personnel because it may involve a clinic visit solely for this purpose,” it will allow doctors and nurses to prescribe the medication remotely.

The letter, sent on Monday to the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, states that the agency will exercise “enforcement discretion” in allowing abortion medication to be prescribed without requiring an in-person doctor’s visit.

Republican lawmakers warned against removing the requirement that the abortion medication be prescribed in person. Sen. Ben Sasse (R., Neb.) accused the Biden administration of exploiting the pandemic to advance the interests of the abortion industry.

“This move by the FDA is just using COVID-19 as a cover to dispense abortion-inducing medication remotely,” Sasse said. “We are over a year into this pandemic with health care largely returning to safe, in-person delivery. This isn’t about pandemic caution—it’s a political move to increase abortions.”

https://freebeacon.com

SCOTUS Blocks Restrictions on Federal Abortion Pill Delivery

Tauren Dyson – October 8, 2020

A Supreme Court ruling will temporarily prevent the enforcement of FDA restrictions that require women to pick up an abortion pill from the doctor during the coronavirus pandemic and will instead allow the medication to be mailed, according to NPR.

The decision lets women continue to get an abortion pill by mail after the high court pushed the case back down to a Maryland federal court for further review.

Three months ago, a federal judge in Maryland decided healthcare providers can have mifepristone mailed to patients. The drug was approved by the FDA in combination with misoprostol to terminate an early pregnancy.

American College of Obstetricians and Gynecologists challenged the FDA regulation since the agency has eased similar restrictions for medications such as opioids.

“It is a relief that for the next few weeks the Trump administration cannot force abortion patients to needlessly risk contracting a life-threatening disease as a condition of obtaining care,” said Julia Kaye, lead counsel for ACOG. “When President Trump is trying to rush through a third Supreme Court justice with the express goal of overturning Roe v. Wade, the court’s delayed ruling in this case gives little comfort that the right to abortion is secure.”

The Supreme Court asked for the Maryland federal judge to reevaluate the rule within 40 days, keeping the high court from acting any more on the issue until after the election.

https://www.newsmax.com